Antivirals
|
|
Your reliable supplier of generic medications.
|
|
|
We have received both parts of the shipment, and my husband and I are very satisfied with the product.
Our billing is certified by:
- What’s best at beating swine flu, soap or gel?
Commuters obsessively scrub their hands with gel.
- Swine flu drug treatment will replace containment strategy
More than 150 people have been diagnosed with swine flu over the past 24 hours as the rate of infection accelerates, pushing the total number of UK cases above 1,000.
- Is the flu jab a waste of time?
On balance, probably not.
- Global flu pandemic would probably kill 62m, study says
Around 62 million people in the world are likely to die if there is a flu pandemic and more than 70,000 of those deaths will be in the UK, according to a statistical analysis published today.
- Vaccine against lethal strain of avian flu ready for human testing
A British drug company is seeking permission to conduct the first human trials of an experimental vaccine against the avian flu virus.
- Public weighs in on pandemic antiviral distribution - CIDRAP
Public weighs in on pandemic antiviral distributionCIDRAPMay 18, 2012 (CIDRAP News) – The Institute of Medicine (IOM) yesterday shared findings of three public opinion panels on antiviral distribution during a flu pandemic, including a nod for establishing diverse alternative strategies and support for Web .
- Antiviral research and Neutron Star System behaviours earn BC students ... - Canada NewsWire (press release)
Antiviral research and Neutron Star System behaviours earn BC students .
- Broad-Spectrum Antivirals: The Future of HIV Treatment? - TheBody.com
Broad-Spectrum Antivirals: The Future of HIV Treatment?TheBody.
- Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs ... - MarketWatch (press release)
Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs .
- New Antivirals Show Poor Safety in HCV With Cirrhosis - Medscape
New Antivirals Show Poor Safety in HCV With CirrhosisMedscapeMay 2, 2012 (Barcelona, Spain) — Two relatively new direct-acting antiviral drugs have poor safety profiles in patients with hepatitis C virus (HCV) and cirrhosis, including a high rate of serious adverse events leading to study discontinuation.
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
